To improve stroke care, the Brain Attack Coalition recommended establishing primary stroke center (PSC) and comprehensive stroke center (CSC) certification. This study aimed to compare ischemic stroke care and in-hospital outcomes between CSCs and PSCs.
S
troke is the fifth leading cause of death in the United States and the leading cause of long-term disability.
1 To improve the delivery of evidencebased stroke care, the Brain Attack Coalition suggested that 2 levels of stroke centers should be established: primary stroke center (PSC) and comprehensive stroke center (CSC). 2 A PSC has the necessary staffing, infrastructure, and programs to stabilize and treat most patients with acute stroke. 2 A CSC should provide complete care to patients experiencing the most complex strokes that require specialized testing and interventions. 2 CSCs are also expected to act as resource centers for other facilities in their region. 2 Similarly to the Unites States, European Stroke Organization recommended to establish 2 levels of stroke care certification: Stroke Unit and Stroke Center, in participating European countries. 3 Interhospital transfer is a resource-intensive pattern of care. 4 Transferred patients had higher in-hospital mortality compared with patients who were directly admitted from the emergency room and were more likely to experience complications. 5 It remains unclear whether CSCs have better performances and outcomes than PSCs for transferred patients and emergency department (ED) admissions in the United States.
The majority of stroke centers participate in the Get With The Guidelines (GWTG)-Stroke program, which collects prospective data for evidence-based and guideline-directed performance measures, and in-hospital outcomes. 6, 7 This study aimed to compare the performances of CSCs and PSCs for quality of care and in-hospital outcomes in treating patients with ischemic stroke. Given the presumed different disease severity and triage algorithm, patients who were admitted directly from the ED admissions and those who were transferred in (transfer-in patients) were examined separately.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results. Study data are confidential and cannot be shared according to the terms of the contracts signed between participating hospitals and the American Heart Association.
GWTG-Stroke is an ongoing voluntary web-based registry and performance improvement initiative that collects patient-level data on patient characteristics, diagnostic testing, treatments, adherence to quality measures, and in-hospital outcomes in patients hospitalized with stroke. Trained hospital personnel are instructed to collect data of consecutive patients treated for acute ischemic stroke by prospective clinical identification, retrospective identification using International Classification of Diseases Ninth Revision codes, or a combination. 6, 7 Additional descriptions of the case ascertainment, data collection, and quality auditing methods have been previously published. 6, 7 Although large, urban, and teaching hospitals are overrepresented, the patients included in GWTG-Stroke have similar characteristics to the overall US Medicare stroke population. 8 Each participating hospital received either human research approval to enroll cases without individual patient consent under the common rule or a waiver of authorization and exemption from subsequent review by their institutional review board. The Duke Clinical Research Institute serves as the data analysis center and has an agreement to analyze the aggregate deidentified data for research purposes.
Patient Population
This study included patients who were admitted to CSCs and PSCs that participated in the GWTG-Stroke program between January 1, 2013, and December 31, 2015, with a final diagnosis of acute ischemic stroke. During the study period, 1626 hospitals in the United States were certified as stroke centers. Among them, 165 hospitals were CSCs, and 1461 hospitals were PSCs. Seventy-three percent of the certified stroke centers participated in the GWTG-Stroke, including 134 CSCs and 1047 PSCs. The final study population consisted of 605 136 ED admission and 117 805 transfer-in patients. Patients without the ischemic stroke diagnosis (n=1 302 419), discharge status missing or those who left against medical advice (n=6874), and those whose transfer information was missing (n=3906) were excluded. We excluded in-hospital stroke (n=18 360) because they represent a unique patient population compared with community-onset stroke. 
Stroke Center Certification and Hospital Data
The hospitals that were listed as having maintained or obtained CSC or PSC certification by the Joint Commission, Healthcare Facilities Accreditation Program, and Det Norske Veritas during the study period were publically available online at www. qualitycheck.org, www.hfap.org, and http://dnvglhealthcare. com. The lists of CSCs and PSCs certified by the state agencies were obtained from the state health department websites.
WHAT IS KNOWN
• Two levels of stroke centers, primary stroke centers (PSCs) and comprehensive stroke centers (CSCs), were established to provide evidence-based stroke treatment and improve the quality of stroke care.
WHAT THE STUDY ADDS
• CSCs and PSCs achieved similar overall care quality for acute ischemic stroke patients, with some exceptions.
• CSCs exceeded PSCs for timely acute reperfusion therapy, including intravenous thrombolytic therapy and endovascular thrombectomy.
• The risk-adjusted in-hospital mortality was modestly higher at CSCs than PSCs but similar between CSCs and PSCs in patients who received acute reperfusion therapy.
• These findings may have important implications for stroke triage and targeted quality improvement at CSCs and PSCs.
Data on hospital characteristics (ie, bed size, academic status, and geographical region) were obtained from the American Hospital Association annual survey database.
Stroke Measure Definitions
The American Heart Association/American Stroke Association came to an agreement with the Joint Commission and the Centers for Disease Control and Prevention to jointly release a set of standardized stroke performance measures. 10 The 7 GWTG-Stroke performance measures and 8 quality measures were previously published. 6, 7 An all-or-none measure of care, termed as defect-free care, was used to summarize the overall conformity with the 7 achievement measures for each hospital. 6 These measures and additional in-hospital outcomes were specified in Table I in the Data Supplement.
Statistical Analysis
The patient demographics, comorbidities, and hospital characteristics were compared between CSCs and PSCs. Because of the large sample size, statistical significance was detected in nearly all the measures despite often small differences. To avoid the influence of the sample size, standardized differences were calculated, using the difference in the mean of a variable between 2 groups divided by the SD of that variable. Standardized difference >10% was considered significant imbalance. Hospital performances in ED admissions, transferin patients, and overall patients with ischemic stroke were compared between CSCs and PSCs. Pearson χ 2 test was used for categorical variables, and Wilcoxon rank-sum test was used for continuous variables.
Multivariable logistic regression models were generated to examine the association between the performance and stroke center certification (CSC versus PSC). The generalized estimating equation method with exchangeable working correlation matrix was applied to provide valid inference to account for in-hospital clustering. The adjusted models were controlled for potential confounders as previously described: patient age, sex, race, medical history of atrial fibrillation/flutter, prior stroke/transient ischemic attack, coronary artery disease/ prior myocardial infarction, carotid stenosis, diabetes mellitus, peripheral vascular disease, hypertension, dyslipidemia, smoking, heart failure, arrival during off hours, hospital annual ischemic stroke admission, annual intravenous tPA (tissuetype plasminogen activator) volume, number of beds, region, academic status, and urban/rural location. 11 The collinearity between all covariates in the model was assessed using variance inflation factors. Large variance inflation factors (>5) may be indicative of collinearity. The correlation between variables with variance inflation factors >5 and the other covariates was examined. When there was evidence of strong correlation between 2 covariates, 1 covariate may need to be dropped from the candidate list to achieve a stable model fit. The mode of arrival (arrival by emergency medical service) was included in the modeling for ED admissions, not transfer-in patients. Because of skewed distribution of door to intravenous tPA time and door to endovascular thrombectomy (EVT) therapy time, Poisson regression model with log link was used, and risk ratios were reported. The quality measure door to intravenous tPA time ≤60 minutes had few eligible patients in the transferin cohort, so it was not included in the modeling analysis.
National Institutes of Health Stroke Score (NIHSS), a surrogate of stroke severity, was not included in the primary analysis because of high missing rate in GWTG-Stroke (up to 15%). As previously reported, the missing of NIHSS in GWTG-Stroke may not be completely random early on when the report rate was low. 12 NIHSS was missing more often in patients with less severe stroke. 13 Sensitivity analyses were further performed where the NIHSS score was added to the models. As secondary analyses, we compared the performance and outcomes between CSCs versus PSCs among patients who received acute reperfusion therapy, intravenous tPA, and EVT, separately. NIHSS report rate was 100% in patients who received intravenous tPA and EVT treatment; thus, it was included in the modeling.
All statistical analyses were performed using SAS version 9.4 software (SAS Institute). All hypothesis tests were 2 sided, with P<0.05 considered statistically significant.
RESULTS
The patients' demographics and comorbidities are shown in Table 1 . There were few differences between CSCs and PSCs in patient characteristics. Overall, patients at CSCs were younger, more likely arrived by emergency medical services, and had more severe stroke represented by higher NIHSS score. Patients who were transferred to CSCs had higher NIHSS than those transferred to PSCs (standardized difference, −10.87).
The hospital characteristics at patient level and hospital level are shown in Table 2 . CSCs were larger than PSCs in terms of total number of beds and annual ischemic stroke volume. CSCs had higher annual intravenous tPA volume than PSCs. More CSCs were teaching hospitals. The performances and in-hospital outcomes are shown in Table 3 . Both CSCs and PSCs had overall good conformity to the 7 performance measures and the summary defect-free care measure. However, CSCs outperformed PSCs in several key measures in treating ED admissions, especially for intravenous tPA and EVT therapy. Compared with PSCs, more patients at CSCs who arrived by 2 hours of stroke onset received intravenous tPA by 3 hours, and more patients who arrived by 3.5 hours received intravenous tPA by 4.5 hours. The proportion of patients with door to intravenous tPA time ≤60, ≤45, and ≤30 minutes were all much higher at CSCs than PSCs. Among all patients with ischemic stroke, CSCs had higher intravenous tPA and EVT therapy rates than PSCs (14.3% versus 10.3%, 4.1% versus 1.0%, respectively). The median door to intravenous tPA time at CSCs was 9 minutes shorter than that at PSCs. The median door to EVT therapy time at CSCs was 7 minutes shorter than that at PSCs. Interestingly, CSCs had higher mortality than PSCs (4.6% versus 3.8%; Table 3 ).
CSCs and PSCs had similar conformity to the performance measures in treating transfer-in patients except that CSCs had higher EVT therapy rates than PSCs (8.5% versus 4.3%). Transferred patients had much higher mortality and lower discharge home rates than ED admissions in both CSCs and PSCs (Table 3) .
We further examined the association of performance with stroke center certification status (CSC versus PSC) using multivariable logistic regression analysis. The forest plots of the adjusted odds ratios are shown in Figures 1 and 2 . Detail results including the unadjusted odds ratios are shown in Tables II  and III Table II in the Data Supplement) . Compared with PSCs, the door to intravenous tPA time at CSCs was 15% shorter in the unadjusted model and 8% shorter in the adjusted model. Patients at CSCs were more likely to receive intravenous tPA with door to needle time ≤60, ≤45, and ≤30 minutes in both the unadjusted and adjusted models. Patients at CSCs were more likely to receive intravenousintravenous tPA within 3 or 4.5 hours if they arrived by 2 or 3.5 hours, respectively, in the unadjusted model but not after risk adjustment. The risk-adjusted door to EVT therapy time for patients at CSCs was 7.8% shorter than that at PSCs. The intravenous tPA and EVT rates among all the ED admissions were higher at CSCs StdDiff was calculated using the difference in the mean between 2 groups divided by the pooled SD of a variable. StdDiff >10% or <−10% were considered significant imbalance. The overall population included ED admissions and those patients who presented from nonacute care hospitals. CSC indicates comprehensive stroke center; ED, emergency department; EMS, emergency medical services; HF, heart failure; IQR, interquartile range; NIHSS, National Institute of Health Stroke Scale; PAD, peripheral vascular disease; PSC, primary stroke center; StdDiff, standardized difference; and TIA, transient ischemic attack. Standardized difference >10% or <−10% was considered imbalance. CSC indicates comprehensive stroke centers; IV tPA, intravenous tissue-type plasminogen activator; and PSC, primary stroke centers.
than PSCs. For in-hospital outcomes, CSCs had higher in-hospital mortality than PSCs although the odds were smaller after risk adjustment. More patients at CSCs had length of stay >4 days in the unadjusted model but not the adjusted model.
CSCs and PSCs showed similar overall performance in treating transferred patients except for EVT therapy and in-hospital mortality (Figure 2 ; Table II in the Data  Supplement) . Patients who were transferred to CSCs were more likely to undergo EVT therapy than those Standardized difference >10% or <−10% was considered imbalance. CSC indicates comprehensive stroke center; DVT, deep vein thrombosis; ED, emergency department; EVT, endovascular thrombectomy; IQR, interquartile range; IV tPA, intravenous tissue-type plasminogen activator; LDL, low-density lipoprotein; NIHSS, National Institute of Health stroke scale; PSC, primary stroke center; and StdDiff, standardized difference. who were transferred to PSCs. CSCs had shorter riskadjusted door to EVT therapy time than PSCs. The riskadjusted discharge home rate was lower at CSCs, and in-hospital mortality was higher. The above findings did not significantly change in the sensitivity analyses where the NIHSS score was added to the models (Table  III in the Data Supplement) .
In the secondary analysis, we compared the performances and outcomes between CSCs and PSCs for ED admissions that received intravenous tPA and EVT therapy. The performances and in-hospital outcomes are shown in Table IV in the Data Supplement. The adjusted odds ratios are shown in Figures 3 and 4 . Detail results of the multivariable analysis including the unadjusted odds ratios are shown in Table V in the Data Supplement. Similar to the primary analysis, patients at CSCs had shorter door to intravenous tPA time, more likely to receive intravenous tPA within 60, 45, and 30 minutes than those at PSCs. The patients who received intravenous tPA at CSCs were more likely to receive EVT therapy. CSCs had shorter door to EVT time in the unadjusted model but not the adjusted model. The risk-adjusted in-hospital outcomes, including mortality, discharge home rate, discharge modified Rankin scale, and ambulatory status, did not differ between CSCs and PSCs in this population.
DISCUSSION
This study compared the performance of CSCs and PSCs that participated in the GWTG-Stroke program in The multivariable logistic regression analysis was adjusted for potential confounders. †Because of skewed distribution, Poisson regression models with log link was used for these 2 variables, and the results shown were risk ratios. Higher odds ratio or risk ratio indicated that the performance or outcome occurred more frequently in CSCs. *Represented P<0.05. **Represented P<0.001. EVT (endovascular thrombectomy) hospitals denote hospitals that performed EVT. AF indicates atrial fibrillation; DVT, deep vein thrombosis; IV tPA; intravenous tissue-type plasminogen activator; LDL, low-density lipoprotein; ND, not documented; and NIHSS, National Institute of Health Stroke Scale.
treating patients with ischemic stroke. For many components of care for patients with acute ischemic stroke, including the defect-free care measure, performance was comparable at CSCs and PSCs. These findings suggest for these domains of care both CSCs and PSCs are capable of achieving similar care quality for patients with acute ischemic stroke. CSCs did exceed PSCs in performance on several key measures of acute reperfusion therapies for ED admissions. CSCs had shorter door to intravenous tPA times and door to EVT therapy time than PSCs. At CSCs, significantly more patients had door to intravenous tPA time ≤60, 45, and 30 minutes. CSCs had higher EVT rates in treating ED admissions than PSCs. In-hospital mortality was found to be modestly lower in PSCs compared with CSCs. This study identifies opportunities for PSCs, as well as CSCs to improve the acute stroke care.
Improved treatment rates and more timely treatment with intravenous tPA therapy by hospitals are essential components of stroke care quality. Intravenous tPA and endovascular thrombectomy have been proven to improve the outcome of acute ischemic stroke in randomized trials. [14] [15] [16] Earlier thrombolytic treatment was associated with reduced mortality and symptomatic intracranial hemorrhage, higher rates of independent ambulation at discharge and discharge to home after acute ischemic stroke. 17 Meta-analysis of clinical trials of patients with large-vessel ischemic stroke showed that earlier treatment with endovascular thrombectomy was associated with lower degrees of disability at The multivariable logistic regression analysis was adjusted for potential confounders. †Because of skewed distribution, Poisson regression models with log link was used for these 2 variables, and the results shown were risk ratios. Higher odds ratio or risk ratio indicated that the performance or outcome occurred more frequently in CSCs. *Represented P<0.05. **Represented P<0.001. EVT (endovascular thrombectomy) hospitals denote hospitals that performed EVT. AF indicates atrial fibrillation; DVT, deep vein thrombosis; IV tPA, intravenous tissue-type plasminogen activator; LDL, low-density lipoprotein; ND, not documented; and NIHSS, National Institute of Health Stroke Scale.
3 months. 18 The advantages of CSCs over PSCs in providing acute reperfusion therapy did not translate into better in-hospital outcomes in our study. Whether such benefits would be apparent in postdischarge follow-up requires further study.
This study showed modest differences in in-hospital mortality favoring PSCs. These differences, although persisted, were attenuated when adjusting for stroke severity. More patients at CSCs had length of stay >4 days in the unadjusted model. Although the result could have been influenced by residual confounding, it may indicate an opportunity for further quality improvement in the CSCs. Further study of other care quality measures, such as postdischarge mortality, functional outcomes, and readmissions, will be helpful to understand the differences between CSCs and PSCs.
Our results confirmed that PSCs provide similar care quality to that of CSCs for interhospital transfer of acute ischemic stroke when EVT therapies were not needed. Among transfer-in patients, NIHSS was modestly higher in CSCs than PSCs, indicating more patients with severe stroke were transferred to CSCs. We suspect that CSCs received more transferred patients who needed EVT therapy resulting in higher EVT rates. Many PSCs may not provide EVT and transfer patients to CSCs. A less likely explanation would be that PSCs were reluctant to provide EVT therapy. The time period over which the data were collected was before the most recent EVT trials that provided sufficient evidence to make it routine practice.
14 It is possible that the low rates of EVT particularly in PSCs, and potentially low numbers transferred to CSCs for intervention, reflected The multivariable logistic regression analysis was adjusted for potential confounders. †Because of skewed distribution, Poisson regression models with log link was used for these 2 variables, and the results shown were risk ratios. Higher odds ratio or risk ratio indicated that the performance or outcome occurred more frequently in CSCs. *Represented P<0.05. **Represented P<0.001. AF indicates atrial fibrillation; DVT, deep vein thrombosis; IV tPA, intravenous tissue-type plasminogen activator; LDL, low-density lipoprotein; and ND, not documented. the evidence-base and presumed risk associated with the procedure. Study using GWTG-Stroke has shown an increase in EVT after the publication of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN) and the pivotal trials. 19 It is notable that the onset to arrival time in transferred patients was ≈3 hours longer than that in the ED admissions. If this delay happened in patients who were EVT therapy candidates, it might have disqualified many patients from EVT therapy. A prior study had shown that 1 of 3 patients became ineligible for EVT because of unfavorable deterioration on neuroimaging after interhospital transfer. 20 Timely transport of patients to an endovascular-capable hospital is crucial because delay to reperfusion was associated with less favorable degree of disability and less functional independence. 18 The current triage algorithm needs to be modified to ensure the fastest possible reperfusion therapy.
This study has important limitations. Participation in GWTG-Stroke is voluntary, and data on patient characteristics and quality measures were self-reported by participating hospitals. However, prior quality audits of GWTG-Stroke data showed high concordance rates with source documentation. 7 Stroke centers that did not participate in the GWTG-Stroke program were not included in this study although the number of such centers is small. We cannot determine whether a greater proportion of patients who were triaged to CSCs were eligible for intravenous tPA or EVT therapy. The modified Rankin scale at discharge was not available in a significant proportion of patients, so it was not used in the primary analysis. There might be unmeasured confounding factors that may influence the results of the The multivariable logistic regression analysis was adjusted for potential confounders. †Because of skewed distribution, Poisson regression models with log link was used for these 2 variables, and the results shown were risk ratios. *Represented P<0.05. EVT indicates endovascular thrombectomy; IV tPA, intravenous tissue-type plasminogen activator; and mRS, modified Rankin scale. multivariable analyses. Although in-hospital mortality is an important in-hospital outcome measure, and we adjusted for comorbid conditions and other risk factors, it can be influenced by stroke severity, transfer policies, length of stay, and other unmeasured confounding factors. Other measures to assess care quality were not collected in this study, including procedure complications, health status, patient satisfaction, and postdischarge outcomes, such as mortality, functional status, and preventable readmissions.
CONCLUSIONS
This study showed that CSCs and PSCs achieved similar overall care quality for patients with acute ischemic stroke. CSCs exceeded PSCs for timely acute reperfusion therapy in treating ED admissions. CSCs and PSCs had comparable performance in treating transferred patients, except that patients who were transferred to CSCs were more likely to undergo EVT. The risk-adjusted in-hospital mortality was modestly higher at CSCs than PSCs in both ED admissions and transfer-in patients. The risk-adjusted in-hospital mortality and functional outcomes were similar in CSCs and PSCs for patients undergoing reperfusion therapy. These findings suggest that both CSCs and PSCs are capable of and achieving similar care quality for patients with acute ischemic stroke, with some exceptions. PSCs have further opportunities to improve the rate and timing for reperfusion therapies, including intravenous tPA and EVT therapy. The findings from this study may have important implications for stroke triage to PSCs versus CSCs, targeted quality improvement at CSCs and PSCs, and for further improving stroke systems of care.
ARTICLE INFORMATION

